Results 151 to 160 of about 13,609,159 (181)
Some of the next articles are maybe not open access.
Myo-inositol vs. D-chiro inositol in PCOS treatment.
Minerva ginecologica, 2015Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women in fertile age. It is an endocrine and metabolic disorder characterized by oligo-anovulation, hyperandrogenism and insulin-resistance. Various therapeutic approaches have been attempted in PCOS, including diet and the use of pharmacological agents such as oral ...
Formuso C +2 more
openaire +3 more sources
D-Chiro Inositol in Lowering Androgen Levels in Pcos Patients
Pakistan Journal of Medical and Health Sciences, 2022Background and objectives: PCOS affects the endocrine, metabolic, and reproductive systems, resulting in the production of cysts in the women who have it. When provided, D-chiro inositol, a new therapeutic agent, has the potential to enhance the patient's endocrine profile.
Anza Ashraf +4 more
openaire +1 more source
D-Chiro-inositol and PCOS: between myth and reality. The never-ending story
International Journal of Food Sciences and Nutrition, 2022Polycystic ovary syndrome (PCOS) is one of the most common disorders among women of reproductive age and can be diagnosed when at least two of the following criteria are present: chronic ovulatory disorder, clinical and/or biochemical hyperandrogenism, and polycystic ovaries.
Cianci A, Vitale Salvatore Giovanni
openaire +3 more sources
Metabolic engineering Corynebacterium glutamicum for D-chiro-inositol production
World Journal of Microbiology and BiotechnologyD-chiro-inositol (DCI) is a potential drug for the treatment of type II diabetes and polycystic ovary syndrome. In order to effectively synthesize DCI in Corynebacterium glutamicum, the genes related to inositol catabolism in clusters iol1 and iol2 were knocked out in C. glutamicum SN01 to generate the chassis strain DCI-1.
Guohui, Ji, Xia, Jin, Feng, Shi
openaire +2 more sources
Effects of D-Chiro-Inositol in Lean Women with the Polycystic Ovary Syndrome
Endocrine Practice, 2002To determine whether the administration of D-chiro-inositol, a putative insulin-sensitizing drug, would affect the concentration of circulating insulin, the levels of serum androgens, and the frequency of ovulation in lean women with the polycystic ovary syndrome.In 20 lean women (body mass index, 20.0 to 24.4 kg/m 2) who had the polycystic ovary ...
Maria J, Iuorno +6 more
openaire +2 more sources
d-chiro-inositol phosphoglycan expression in human placenta at term in diabetes
Archives of Gynecology and Obstetrics, 2013We present a histological assessment of diabetic placenta for the localization of some insulin mediators that were reported to play a major role for lipid/glycogen metabolism in human placenta. Placental metabolism is fundamental to fetal wellbeing.
Scioscia M +4 more
openaire +3 more sources
d-chiro-Inositol enhances effects of hypothalamic toxin gold-thioglucose
Brain Research, 2003D-chiro-Inositol (DCI) enhances reproductive function in insulin-resistant women with polycystic ovarian disease and enhances the effects of insulin in the periphery, suggesting that this compound may act in part by sensitizing the hypothalamus to effects of insulin.
Fumiko, Isoda +4 more
openaire +2 more sources
New clinical targets of d-chiro-inositol: rationale and potential applications
Expert Opinion on Drug Metabolism and Toxicology, 2020Vittorio Unfer +2 more
exaly